Buy Asbestos Leads Direct - No Broker Layer
Most vendors make you sit through a discovery call before they will tell you what a mesothelioma lead costs. We publish the structure instead: what each tier includes, indicative price ranges by claim type, minimum commitments, how delivery works, and exactly what happens when a lead misses spec. Pre-screened asbestos and mesothelioma leads for attorneys — exclusive by default, never resold, never aged, and replaced free if the file fails the criteria we agreed in writing.
Pricing and availability last reviewed . New to the litigation? Start with our asbestos lawsuit leads overview →
Decide This First
Before price enters the conversation, decide which asset your firm actually wants. A qualified lead and a signed retainer are different products with different economics, and vendors who blur the line are usually selling the cheaper one at the more expensive price.
A pre-screened asbestos claimant who has cleared our four-screen qualification and consented to be contacted about legal representation. Your intake team makes the call, builds the relationship, and signs the retainer. Available as standard web leads or live transfer leads.
Best for firms with a staffed intake department that already converts well and wants volume at the top of the funnel.
An intake-ready case rather than a lead. The claimant arrives with an executed retainer agreement and a completed intake file: diagnosis details, exposure history, employment timeline, and consent documentation already captured.
Best for firms without intake headcount, or firms that would rather buy certainty than manage a conversion funnel.
Published Pricing
Three claim types, two tiers each. They do not share a price because they do not share a recovery path or a case value, and pretending otherwise is how firms end up overpaying for the cheap category and underbuying the expensive one.
| Claim Type | Qualified Lead | Signed Retainer | What Drives the Price |
|---|---|---|---|
| Mesothelioma Pleural & peritoneal |
$900–$1,500per lead | $9,000–$18,000per retainer | The scarcest and highest-value category. Roughly 3,000 US diagnoses a year against nationwide firm demand, with average case values in the $1M–$2M+ range. Biopsy confirmation and pre-1985 exposure documentation are what you are paying for. |
| Asbestos Lung Cancer Occupational exposure |
$450–$800per lead | $4,500–$9,000per retainer | Higher diagnosis volume than mesothelioma but a harder causation story, since smoking history has to be disclosed and worked into the file. Priced below meso, and the qualification screen matters more here than anywhere else. |
| Talc / MDL 2738 Meso & ovarian cancer |
$250–$500per lead | $2,500–$5,000per retainer | The live federal action, with roughly 68,000 pending cases and steady inventory. Lower per-unit cost, higher volume, and an MDL pathway rather than state court — so it is qualified and priced as its own category. |
| Wrongful Death / Estate Any of the above |
Add 10–20%on base rate | Quoted per filecase by case | Estate representative identification, probate posture, and the survival-versus-wrongful-death election add qualification work up front. Priced as a modifier on the underlying claim type rather than a separate line. |
Cost per signed case is the only figure that survives contact with a real docket — cost per lead on its own hides the conversion rate that actually decides your acquisition budget.
Industry Benchmarks
Before you compare asbestos lead prices between vendors, it helps to know what plaintiff acquisition costs across the wider legal market. Legal services carry one of the highest cost-per-lead profiles of any industry — roughly $650–$800 on average against a cross-industry mean nearer $198 — and mass tort sits at the top of that range.
| Acquisition Channel | Avg Cost Per Lead | Lead-to-Case Rate | Cost Per Signed Case |
|---|---|---|---|
| Exclusive mass tort leads What we sell |
$300–$1,000+ | 14–22% | Lowest true cost per retained case in the category, because the conversion rate carries the price |
| Shared / aged / recycled leads The cheap option |
Lowest headline price | 3–6% | Highest true cost per signed retainer once you run the math on wasted intake hours |
| Pay-per-lead platforms Directory / marketplace |
$50–$150+ | 3–10% | $1,500–$6,000 |
| Google Ads (PPC) Run in-house |
$442 | 5–15% | $2,900–$8,800 |
| Google Local Services Ads Run in-house |
$378 | 8–12% | $3,150–$4,725 |
| SEO / organic Long build, best economics |
$183 | 15–20% | $915–$1,220 |
Across all mass torts, the 2026 median cost per signed retainer sits near $3,850, ranging from roughly $2,500 on lower-value torts to $12,000+ on the most competitive. Asbestos and mesothelioma sit at the upper end — and should, given average case values in the $1M–$2M+ range. The firms that win this vertical are the ones that stopped negotiating cost per lead and started measuring cost per signed case.
Benchmarks compiled from published 2026 legal marketing industry data. Your firm's actual figures will vary with jurisdiction, intake speed, and claim type.
The Buying Process
No discovery-call theatre and no three-week onboarding. Four steps, each with something in writing at the end of it, so you know what you bought before you fund anything.
Claim types, states you can file in, monthly volume, lead or retainer. We write the qualification criteria into a criteria sheet before pricing is even discussed.
We check live inventory against those criteria and return real counts and firm pricing. If we cannot supply your volume without loosening the screen, we tell you rather than quietly loosening it.
You approve criteria, volume, and replacement terms in one agreement. We configure delivery into your CRM, intake platform, or a secure inbox and agree the weekly cadence.
Delivery starts once your criteria are configured and inventory is confirmed. Anything off-spec gets flagged and replaced free, and we review conversion and cost per signed case with you as the campaign runs.
Every one of those four steps produces a document. If a vendor cannot show you a written criteria sheet before you pay, you are not buying leads — you are buying whatever they happen to have that month.
What Every Lead Must Clear
Asbestos is the one mass tort where the qualification screen is worth more than the contact data. Exposure happened thirty to sixty years ago, the defendants may be in bankruptcy trusts, and the statute of limitations runs from diagnosis rather than exposure — so a name without a documented history is not a case, it is a research project.
These are the standing criteria. You can tighten any of them for your campaign, and we price accordingly.
Documented diagnosis claim, not a self-reported suspicion. Biopsy confirmation captured where available, with diagnosis date recorded because it starts the limitations clock in most states.
Identified exposure source and time period, weighted toward pre-1980s occupational contact where an identifiable defendant or trust still exists. Take-home and secondary exposure captured separately, since those files build differently.
Screened against diagnosis date and the filing state's limitations period, including wrongful death and survival distinctions. You should never be handed a claim that was time-barred before it reached your inbox.
Flagged to a likely route — active state-court docket, bankruptcy trust recovery, or the talc MDL — with potential defendants and trust eligibility noted. Setoff-rule states are marked so filing sequencing protects net recovery.
Inbound origin only. The claimant requested information, TCPA consent is captured with timestamp and source, and no runner, cold call, or purchased list touches the file at any point.
Occupational exposure profiles we screen and tag on every asbestos lead before it reaches your intake team.
The Return Policy
The single most common complaint about buying asbestos leads is a replacement promise that evaporates the moment you try to use it. Ours is a term of the agreement, which makes it enforceable rather than discretionary.
The criteria sheet is signed before delivery starts. Because "qualified" is defined in the document rather than in a sales conversation, there is nothing to argue about later.
Report an off-spec lead inside the agreed window with the reason it failed. No escalation ladder, no requirement to prove you worked it for thirty days first.
A qualifying replacement is issued against your existing commitment. You are not credited toward a future order you may never place, and you are not charged for the replacement.
Worth saying plainly: no replacement policy covers a lead that simply declined to retain your firm. It covers leads that failed the criteria we both signed — wrong diagnosis, no qualifying exposure, time-barred, or bad contact data. Any vendor promising to replace non-conversions is either not honouring it or has priced it in already.
Channel Comparison
There are only three realistic ways to add asbestos cases to a docket. Each has a defensible case, and the right answer depends on your intake capacity and how much variance your firm can absorb.
| Buy From Us | Lead Aggregator / Broker | Run Your Own Ads | |
|---|---|---|---|
| Time to first case | Days — firm date confirmed at quote | Days, but often resold inventory | 2–4 months to a stable cost per acquisition |
| Exclusivity | One buyer per lead, never resold | Frequently shared with 3–4 firms | Fully exclusive by definition |
| Upfront cash risk | Monthly commitment, replacement-protected | Low per unit, high waste rate | $15K–$30K/month before the first signed case |
| Qualification depth | Four-screen: diagnosis, exposure era, SOL, forum | Usually contact validation only | Whatever your intake team builds |
| Who owns the claimant relationship | Your firm, from first contact | Shared — you are racing other callers | Your firm |
| Recourse on a bad file | Written replacement policy, no charge | Case-by-case, often credit-only | None — the spend is gone |
| Honest weakness | Higher per-unit price than shared inventory, and monthly minimums mean it is not built for a single test purchase | Cheapest headline number in the market, which is exactly why the cost per signed case is the highest | Best long-run economics if you have the runway, the marketing headcount, and the patience |
Before You Buy
Asbestos is not one litigation. It is three, and a lead priced correctly for one pathway can be worthless on another. This matters commercially, because it is the difference between a file you can move and a file that sits in a drawer.
Full Compliance
The compliance question is the one that stops most firms from buying at all, and it deserves a direct answer. Every claimant is generated through inbound marketing where they actively request information — no runners, no cold calls, no scraped lists. The arrangement is a marketing fee, not fee-sharing from a settlement, which is the distinction ABA guidance and state anti-barratry statutes actually turn on. We operate in full compliance with TCPA, HIPAA, ABA, and applicable federal and state law.
Since 2009
More than 60,000 leads delivered across mass tort, MVA, and personal injury since 2009 — generated in-house, qualified in-house, sold once. Tell us your states and your volume and we will come back with real counts and firm pricing, usually the same day.
Get Started
Tell us your target states, claim types, and monthly volume. You will get current availability, firm pricing, and the per-signed-case math — not a brochure and a callback in a week.
We promise the best quality with the industry's best return policy. No other company offers investment protection like we do.
By submitting, you consent to be contacted by InjuryCaseClaims.com regarding your inquiry. This does not constitute a binding agreement. All information is handled securely and confidentially.
Same Thing, Different Names
Vendors in this space use a dozen different labels for overlapping products, which makes comparison shopping harder than it should be. Here is the plain-language version of what each term actually means, and which of them we supply.
| Term You'll See | What It Actually Means | Do We Supply It? |
|---|---|---|
| Asbestos leads / asbestos case leads | A claimant who has requested legal information about an asbestos-related diagnosis. Quality varies enormously depending on whether anyone screened the diagnosis and exposure history. | Yes — screened, exclusive |
| Mesothelioma leads for attorneys | The narrowest and most expensive subset. Roughly 3,000 US diagnoses a year against nationwide firm demand, which is what drives the price. | Yes — biopsy-confirmed |
| Pre-qualified / pre-screened claimants | Someone has checked the file against acceptance criteria before delivery. The phrase is meaningless unless the vendor shows you the criteria in writing. | Yes — written criteria sheet |
| Intake-ready cases / signed retainers | Executed retainer agreement plus a completed intake file. No conversion risk left on your side of the transaction. | Yes — Tier 2 |
| Live transfer leads | The claimant is transferred to your intake line while still on the phone. Highest conversion, highest per-unit cost, and it requires staffed phone coverage on your end. | Yes — on request |
| Aged leads / recycled leads | Contacts generated weeks or months ago, frequently already sold to other firms. Cheap for a reason, and the single biggest source of complaints in this industry. | No — we don't sell these |
| Shared leads | The same claimant sold to three or four firms simultaneously. You're racing competitors to the phone on a family that is already fielding calls. | Only on specific request |
| Plaintiff acquisition / case acquisition | Agency language for the same activity, usually bundled with media buying and campaign management rather than sold as discrete inventory. | Yes — sold as inventory |
FAQ
The commercial questions, answered directly. For the litigation and qualification detail, see the asbestos lawsuit leads page.